Copyright © BetaNXT, Inc. or its affiliates All Rights Reserved.
The secure way to view our proxy materials and to vote online.
Your vote is IMPORTANT!
Vote your shares online now or by phone by dialing 866-390-5243.
Please vote by 8:59 PM Pacific Time on June 14, 2026.
The meeting will be held entirely online via live audio webcast.
You must register to attend the meeting online and/or to participate in the meeting by 2:00 PM Pacific Time on June 14, 2026.
After registering below, further instructions will be emailed to you, including a unique link to access the meeting.
Guided by science, we are relentlessly committed to bringing transformative new medicines to patients with oncogene amplified cancer. Requisite to our success are boldness, creativity, and collaboration.
United in purpose, we are a team of experienced precision oncology leaders with deep scientific, clinical, diagnostic, and business expertise. We are applying this experience to develop an entirely new vertical of cancer therapeutics, ecDNA-directed therapies (ecDTx).
At Boundless, we’re all in. We are unbound by convention, bound to save lives.